Publications & Posters
Scholarly publications
Cardiometabolic Disease
June 2026
American Diabetes Association 2026 Scientific Sessions
A novel anti-myostatin GLP-1RA fusion molecule to preserve muscle and improve body composition during GLP-1 RA therapy
Cardiometabolic Disease
May 2026
The Essential Protein & Antibody Engineering Summit
Design and Evaluation of a Dual Mechanism GLP-1R Agonist Antibody Fusion for Weight Loss with Lean Mass Preservation
Spinal Muscular Atrophy
Apitegromab
March 2026
SMA Europe 2026
Understanding physical therapist perspectives on the clinical meaningfulness of ‘any point differences’ on the Hammersmith Functional Motor Scale-Expanded in SMA
Spinal Muscular Atrophy
Apitegromab
March 2026
SMA Europe 2026
Understanding neurologist perspectives on the clinical meaningfulness of ‘any point differences’ on the Hammersmith Functional Motor Scale-Expanded in SMA
Facioscapulohumeral Muscular Dystrophy
Apitegromab
March 2026
Muscular Dystrophy Association Clinical & Scientific Conference 2026
Trial design for the Phase 2 FORGE study evaluating apitegromab in adults with facioscapulohumeral muscular dystrophy
Facioscapulohumeral Muscular Dystrophy
Apitegromab
March 2026
Muscular Dystrophy Association Clinical & Scientific Conference 2026
